S&T BANK/PA - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
S&T BANK/PA ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,943
-10.6%
215,578
-2.6%
1.15%
-4.3%
Q2 2023$6,651
-18.0%
221,243
-1.1%
1.20%
-18.2%
Q1 2023$8,107
-21.4%
223,775
-22.6%
1.46%
-23.1%
Q4 2022$10,319
-99.9%
289,269
-4.0%
1.90%
-3.3%
Q3 2022$10,197,000
+12.5%
301,226
-3.9%
1.97%
+23.6%
Q2 2022$9,063,000
-11.4%
313,390
-0.9%
1.59%
+3.2%
Q1 2022$10,224,000
+10.8%
316,326
-0.1%
1.54%
+14.6%
Q4 2021$9,231,000
+9.5%
316,569
+0.1%
1.35%
+3.1%
Q3 2021$8,430,000
-14.1%
316,098
-0.8%
1.31%
-14.2%
Q2 2021$9,813,000
+17.3%
318,682
-0.3%
1.52%
+11.9%
Q1 2021$8,365,000
+3.8%
319,533
-0.2%
1.36%
-5.9%
Q4 2020$8,055,000
+20.9%
320,144
+0.1%
1.45%
-4.9%
Q3 2020$6,663,000
-6.8%
319,738
+6.3%
1.52%
-6.5%
Q2 2020$7,146,000
+30.0%
300,886
-1.5%
1.63%
+7.5%
Q1 2020$5,496,000
-8.7%
305,514
+20.3%
1.51%
+22.7%
Q4 2019$6,021,000
-13.2%
253,855
+0.6%
1.23%
-17.8%
Q3 2019$6,940,000
-13.5%
252,323
+4.0%
1.50%
-14.6%
Q2 2019$8,026,000
+40.5%
242,559
+48.8%
1.76%
+36.7%
Q1 2019$5,712,000163,0341.29%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders